The Hindu Business Line : Divi's Labs net climbs 66 pc at Rs 31 cr

Advertisement

Hyderabad Jan. 27 Divi's Laboratories Ltd clocked a total income of Rs 152 crore (Rs 110 crore) and net profit of Rs 31 crore (Rs 19 crore) on a consolidated basis for the third quarter ended December 31, 2006, showing a growth of 38 per cent in income and 66 per cent in net profit.

The third quarter results include operations from the special economic zone (SEZ) unit at Chippada, Bheemunipatnam near Visakhapatnam also, according to the un-audited financial results announced on Saturday. The basic EPS (earning per share) stood at Rs 25.54 against Rs 14.74 in the previous year's quarter.

The consolidated results include the financials of subsidiaries, Divi's Laboratories, US and Divi's Laboratories, Europe. As no subsidiaries were required to be consolidated as on December 31, 2005, the previous year's figures are not given, the company said in a press release.

Divi's Labs, a major manufacturer of active pharmaceutical ingredients and intermediates, has during the quarter under review filed a Drug Master File with the US Food and Drug Administration for a generic product.

Nine-month income

For the nine-month period, Divi's Labs earned a total income of Rs 482 crore (Rs 262 crore) and a net of Rs 87 crore (Rs 48 crore). While the growth in income was 84 per cent, the net rose by 81 per cent.